Mutant P53 expression in chronic myeloid leukemia
Background: Chronic Myeloid Leukemia (CML) occurs due to malignant transformation of a pluripotent stem cell. Progression is insidious from chronic to aggressive accelerated or blastic phases. Studies revealed a significant role of the tumor suppressor gene P53 in disease progression. Objectives...
Main Authors: | Areej E. Kadhom, Haider H. Al-Shammari |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Medicine University of Baghdad
2013-07-01
|
Series: | مجلة كلية الطب |
Subjects: | |
Online Access: | http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/623 |
Similar Items
-
p53 Gene (NY-CO-13) Levels in Patients with Chronic Myeloid Leukemia: The Role of Imatinib and Nilotinib
by: Hayder M. Al-kuraishy, et al.
Published: (2018-01-01) -
Immunohistochemical study of p-53 protein expression in chronic lymphocytic leukemia and its correlation with clinicopathological factors
by: Abdulrazzaq W. Abdullah, et al.
Published: (2015-04-01) -
P53 gene mutation and protein expression in ameloblastomas
by: Karima Akool Al-Salihi, et al.
Published: (2015-11-01) -
Immunohistochemical expression of p63, p53 in urinary bladder carcinoma
by: Ali Koyuncuer
Published: (2013-01-01) -
Expression of p53 and p21 in bladder carcinoma of Iraqi patients
by: Rawaa Al Chalabi, et al.
Published: (2019-06-01)